Chinese Journal of Dermatology ›› 2012, Vol. 45 ›› Issue (11): 792-795.

• Original articles • Previous Articles     Next Articles

Heat shock protein 70 upregulates interleukin-6 expression by fibroblasts from psoriasis vulgaris lesions

  

  • Received:2011-12-22 Revised:2012-07-14 Online:2012-11-15 Published:2012-10-31

Abstract:

Objective To evaluate the in vitro effect of heat shock protein 70 (HSP70) on interleukin-6 (IL-6) expression by cultured fibroblasts from psoriasis vulgaris lesions(PFbs). Methods Fibroblasts were isolated from the lesions of patients with psoriasis vulgaris and subjected to a primary culture. After 3 to 5 passages of culture, the fibroblasts were collected and used in the next experiment. Some PFbs were cultured with different concentrations (5, 10, 20, 30 mg/L) of HSP70 for 48 hours, or with HSP70 of 30 mg/L for different durations (3, 6, 12, 24, 48, 72 hours); some PFbs were incubated with HSP70 of 30 mg/L for 24 hours after pretreatment with pyrrolidine dithiocarbamate(PDTC, a specific inhibitor of nuclear factor-kappa B) for 30 minutes. PFbs receiving no treatment served as the control. Enzyme-linked immunosorbent assay (ELISA) and semi-quantitative reverse transcription PCR were performed to measure the IL-6 protein expression in culture supernatant and IL-6 mRNA expression by PFbs, respectively. Differences in the expression of IL-6 protein and mRNA between PFbs receiving different treatment were analyzed by using t test and Dunnett′s t test. Results HSP70 significantly increased both protein production and mRNA expression of IL-6 in a time(0-48 h)- and dose(5-30 mg/L)-dependent manner. The expression levels of supernatant IL-6 protein and IL-6 mRNA were significantly higher in the PFbs treated with HSP70 of 10 mg/L for 48 hours than untreated PFbs ((75.2 ± 15.4) ng/L vs. (47.2 ± 10.6) ng/L, 0.439 ± 0.093 vs. 0.249 ± 0.069, both P < 0.05). A significant increase was observed as early as 6 hours in the level of IL-6 mRNA after the treatment with HSP70 of 30 mg/L, and 12 hours in the level of supernatant IL-6 protein. Decreased supernatant IL-6 protein and IL-6 mRNA were noted for PFbs treated with PDTC and HSP70 of 30 mg/L compared with untreated PFbs ((42.23 ± 9.41) ng/L vs. (68.40 ± 14.43) ng/L, 0.144 ± 0.048 vs. 0.295 ± 0.081, both P < 0.05). Conclusion HSP70 may increase the expression of IL-6 mRNA and protein by cultured PFbs via the nuclear factor-kappa B pathway.

Key words: Interleukin-6

CLC Number: 

  • R751